Trial
NCT00261547
Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
Genentech, Inc.
Condition
Chronic Rejection
Intervention
Rituximab
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-23